Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 15 studies | 33% ± 15% | |
peripheral blood | 13 studies | 31% ± 10% | |
intestine | 8 studies | 28% ± 12% | |
kidney | 7 studies | 25% ± 6% | |
brain | 7 studies | 29% ± 6% | |
lymph node | 5 studies | 32% ± 9% | |
liver | 5 studies | 28% ± 13% | |
placenta | 4 studies | 37% ± 15% | |
uterus | 4 studies | 32% ± 18% | |
breast | 4 studies | 25% ± 7% | |
pancreas | 3 studies | 44% ± 4% | |
bone marrow | 3 studies | 20% ± 4% | |
eye | 3 studies | 22% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 3870.53 | 1445 / 1445 | 97% | 3.69 | 178 / 183 |
intestine | 100% | 3525.16 | 966 / 966 | 91% | 2.58 | 481 / 527 |
lung | 100% | 2957.36 | 576 / 578 | 90% | 3.42 | 1042 / 1155 |
brain | 100% | 3720.71 | 2641 / 2642 | 88% | 2.02 | 620 / 705 |
stomach | 100% | 2730.54 | 359 / 359 | 87% | 2.38 | 249 / 286 |
breast | 100% | 3521.17 | 459 / 459 | 86% | 2.46 | 962 / 1118 |
pancreas | 100% | 1922.41 | 328 / 328 | 85% | 2.61 | 151 / 178 |
bladder | 100% | 3327.52 | 21 / 21 | 84% | 2.42 | 421 / 504 |
uterus | 100% | 3450.71 | 170 / 170 | 78% | 2.12 | 357 / 459 |
skin | 100% | 3943.57 | 1809 / 1809 | 75% | 2.04 | 354 / 472 |
ovary | 100% | 3205.37 | 180 / 180 | 72% | 1.81 | 309 / 430 |
prostate | 100% | 3487.16 | 245 / 245 | 69% | 1.44 | 345 / 502 |
thymus | 100% | 4154.17 | 653 / 653 | 68% | 1.37 | 414 / 605 |
kidney | 100% | 3666.61 | 89 / 89 | 68% | 2.00 | 609 / 901 |
adrenal gland | 100% | 5062.11 | 258 / 258 | 56% | 1.03 | 128 / 230 |
liver | 100% | 2253.31 | 226 / 226 | 33% | 0.63 | 133 / 406 |
adipose | 100% | 3203.68 | 1204 / 1204 | 0% | 0 | 0 / 0 |
spleen | 100% | 4083.86 | 241 / 241 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 2943.31 | 1333 / 1335 | 0% | 0 | 0 / 0 |
heart | 98% | 1604.70 | 848 / 861 | 0% | 0 | 0 / 0 |
muscle | 96% | 1202.68 | 768 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 84% | 2491.02 | 779 / 929 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 69% | 1.79 | 20 / 29 |
eye | 0% | 0 | 0 / 0 | 63% | 1.92 | 50 / 80 |
tonsil | 0% | 0 | 0 / 0 | 60% | 1.09 | 27 / 45 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0001525 | Biological process | angiogenesis |
GO_0097190 | Biological process | apoptotic signaling pathway |
GO_0034605 | Biological process | cellular response to heat |
GO_0045766 | Biological process | positive regulation of angiogenesis |
GO_0010595 | Biological process | positive regulation of endothelial cell migration |
GO_0032007 | Biological process | negative regulation of TOR signaling |
GO_1902527 | Biological process | positive regulation of protein monoubiquitination |
GO_0006886 | Biological process | intracellular protein transport |
GO_0030948 | Biological process | negative regulation of vascular endothelial growth factor receptor signaling pathway |
GO_0043280 | Biological process | positive regulation of cysteine-type endopeptidase activity involved in apoptotic process |
GO_0014032 | Biological process | neural crest cell development |
GO_0051898 | Biological process | negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction |
GO_0001938 | Biological process | positive regulation of endothelial cell proliferation |
GO_0014029 | Biological process | neural crest formation |
GO_0036324 | Biological process | vascular endothelial growth factor receptor-2 signaling pathway |
GO_0006888 | Biological process | endoplasmic reticulum to Golgi vesicle-mediated transport |
GO_0051592 | Biological process | response to calcium ion |
GO_0048208 | Biological process | COPII vesicle coating |
GO_0031410 | Cellular component | cytoplasmic vesicle |
GO_0048471 | Cellular component | perinuclear region of cytoplasm |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005654 | Cellular component | nucleoplasm |
GO_0031463 | Cellular component | Cul3-RING ubiquitin ligase complex |
GO_0030127 | Cellular component | COPII vesicle coat |
GO_0070971 | Cellular component | endoplasmic reticulum exit site |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0005768 | Cellular component | endosome |
GO_0005634 | Cellular component | nucleus |
GO_1990756 | Molecular function | ubiquitin-like ligase-substrate adaptor activity |
GO_0042803 | Molecular function | protein homodimerization activity |
GO_0043495 | Molecular function | protein-membrane adaptor activity |
GO_0042802 | Molecular function | identical protein binding |
GO_0000287 | Molecular function | magnesium ion binding |
GO_0048306 | Molecular function | calcium-dependent protein binding |
GO_0030674 | Molecular function | protein-macromolecule adaptor activity |
GO_0046982 | Molecular function | protein heterodimerization activity |
GO_0005509 | Molecular function | calcium ion binding |
GO_0046983 | Molecular function | protein dimerization activity |
GO_0005515 | Molecular function | protein binding |
Gene name | PDCD6 |
Protein name | HCG1985580, isoform CRA_c (Programmed cell death 6) Programmed cell death 6 PDCD6 protein (Programmed cell death 6) Programmed cell death protein 6 (Apoptosis-linked gene 2 protein homolog) (ALG-2) |
Synonyms | ALG2 hCG_1985580 |
Description | FUNCTION: Calcium sensor that plays a key role in processes such as endoplasmic reticulum (ER)-Golgi vesicular transport, endosomal biogenesis or membrane repair. Acts as an adapter that bridges unrelated proteins or stabilizes weak protein-protein complexes in response to calcium: calcium-binding triggers exposure of apolar surface, promoting interaction with different sets of proteins thanks to 3 different hydrophobic pockets, leading to translocation to membranes . Involved in ER-Golgi transport by promoting the association between PDCD6IP and TSG101, thereby bridging together the ESCRT-III and ESCRT-I complexes . Together with PEF1, acts as a calcium-dependent adapter for the BCR(KLHL12) complex, a complex involved in ER-Golgi transport by regulating the size of COPII coats . In response to cytosolic calcium increase, the heterodimer formed with PEF1 interacts with, and bridges together the BCR(KLHL12) complex and SEC31 (SEC31A or SEC31B), promoting monoubiquitination of SEC31 and subsequent collagen export, which is required for neural crest specification . Involved in the regulation of the distribution and function of MCOLN1 in the endosomal pathway . Promotes localization and polymerization of TFG at endoplasmic reticulum exit site . Required for T-cell receptor-, Fas-, and glucocorticoid-induced apoptosis (By similarity). May mediate Ca(2+)-regulated signals along the death pathway: interaction with DAPK1 can accelerate apoptotic cell death by increasing caspase-3 activity . Its role in apoptosis may however be indirect, as suggested by knockout experiments (By similarity). May inhibit KDR/VEGFR2-dependent angiogenesis; the function involves inhibition of VEGF-induced phosphorylation of the Akt signaling pathway . In case of infection by HIV-1 virus, indirectly inhibits HIV-1 production by affecting viral Gag expression and distribution . .; FUNCTION: [Isoform 2]: Has a lower Ca(2+) affinity than isoform 1 (By similarity). . |
Accessions | A0A024QZ42 ENST00000264933.9 [O75340-1] O75340 ENST00000509581.5 A0A087WZ38 ENST00000618970.4 D6RA21 ENST00000505526.1 ENST00000505221.5 [O75340-3] H0Y9X3 ENST00000507473.1 ENST00000507528.5 [O75340-2] Q86W51 ENST00000614778.4 |